ArticleAntonie van Leeuwenhoek2025
Genetic study of extended spectrum beta-lactamase genes; bla-TEM, blaOXA-10, blaSHV and per-1 in pseudomonas aeruginosa from hospital-acquired infections.
Article in Antonie van Leeuwenhoek, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Carbapenem-resistantFrontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudomonas aeruginosa, an opportunistic pathogen, is a major contributor to hospital-acquired infections. This Gram-negative bacterium relies on aerobic respiration and cannot ferment. Various mechanisms of antibiotic resistance closely link to its pathogenicity. This study aimed to determine how common the bla-TEM, blaOXA-10, blaSHV, and per-1 genes were in Pseudomonas aeruginosa samples taken from hospitalized patients. We conducted a retrospective cross-sectional analysis on 100 isolates of the bacterium. The double-disc test detected extended-spectrum beta-lactamase (ESBL) activity and assessed antibiotic susceptibility. Using polymerase chain reaction (PCR), we found that the bla-TEM, bla-SHV, blaOXA-10, and per-1 genes were present. Pseudomonas aeruginosa isolates were highly resistant to meropenem (80%), imipenem (77%), piperacillin (77%), and ceftazidime (76%). However, they were not resistant to colistin. 91% of the isolates exhibited multidrug resistance (MDR), and 76% phenotypically showed ESBL production.Gene analysis revealed that bla-TEM was the most prevalent (38%), then per-1 (31%), bla-SHV (15%), and OXA-10 (9%). We identified the bla-TEM gene in 50.8% of ESBL-positive Pseudomonas aeruginosa, the per-1 gene in 40.8%, and the bla-SHV and OXA-10 genes in 19.7% and 2.6% respectively. The phenotypic method failed to detect ESBL activity in 24 isolates with the per-1 gene and 7 isolates with the OXA-10 gene. In conclusion, clinical isolates of Pseudomonas aeruginosa show a high prevalence of ESBL activity, but reliance on phenotypic methods alone may overlook some cases. The most frequently detected ESBL-associated genes are bla-TEM, followed by per-1, bla-SHV, and OXA-10. Additionally, Pseudomonas aeruginosa isolates demonstrate a high incidence of multiple drug resistance.
Indexed as
Identifiers
40082286What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.